Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Caspofungin acetate (MK-0991) is an antifungal antibiotic that inhibits the synthesis of 1,3-β- d -glucan, an essential component of the cell wall of several pathogenic fungi. Caspofungin acetate was recently approved for the treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies. The activity of 1,3-β- d -glucan synthesis inhibitors against Aspergillus fumigatus has been evaluated in animal models of pulmonary or disseminated disease by using prolongation of survival or reduction in tissue CFU as assay endpoints. Because these methods suffer from limited sensitivity or poor correlation with fungal growth, we have developed a quantitative PCR-based (qPCR) (TaqMan) assay to monitor disease progression and measure drug efficacy. A. fumigatus added to naı̈ve, uninfected kidneys as either ungerminated conidia or small germlings yielded a linear qPCR response over at least 4 orders of magnitude. In a murine model of disseminated aspergillosis, a burden of A. fumigatus was detected in each of five different organs at 4 days postinfection by the qPCR assay, and the mean fungal load in these organs was 1.2 to 3.5 log 10 units greater than mean values determined by CFU measurement. When used to monitor disease progression in infected mice, the qPCR assay detected an increase of nearly 4 log 10 conidial equivalents/g of kidney between days 1 and 4 following infection, with a peak fungal burden that coincided with the onset of significant mortality. Traditional CFU methodology detected only a marginal increase in fungal load in the same tissues. In contrast, when mice were infected with Candida albicans , which does not form true mycelia in tissues, quantitation of kidney burden by both qPCR and CFU assays was strongly correlated as the infection progressed. Finally, treatment of mice with induced disseminated aspergillosis with either caspofungin or amphotericin B reduced the A. fumigatus burden in infected kidneys to the limit of detection for the qPCR assay. Because of its much larger dynamic range, the qPCR assay is superior to traditional CFU determination for monitoring the progression of disseminated aspergillosis and evaluating the activity of antifungal antibiotics against A. fumigatus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · cited 1×
“By using the BLAST algorithm (4), we performed database searches to demonstrate that the selected primer-probe combinations were specific for Aspergillus spp.”
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 2×
“albicans and assessed for percent survival (E) by the Kaplan-Meier technique (20) or for kidney burden by both a CFU ( ) and a qPCR (Œ) assay as described in Materials and Methods.”
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307 · cited 2×
“fumigatus conidia, this method is not adequate for the enumeration of filamentous structures that are not dispersed when spread on agar plates (24).”
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785 · cited 1×
“The value of existing therapies is tempered by such factors as a lack of sufficient spectrum, toxic side effects, or emerging resistance (13, 31, 37).”
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“The value of existing therapies is tempered by such factors as a lack of sufficient spectrum, toxic side effects, or emerging resistance (13, 31, 37).”
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“The value of existing therapies is tempered by such factors as a lack of sufficient spectrum, toxic side effects, or emerging resistance (13, 31, 37).”
Detection and identification of fungal pathogens in blood by using molecular probes
Einsele, H., Hebart, H., Roller, G., Löffler, J., Rothenhofer, I., Müller, C. A., Bowden, R. A., van Burik, J., Engelhard, D., Kanz, L., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1353-1360.1997 · Cited by 581 · cited 1×
“The rRNA gene locus is frequently chosen as the PCR amplicon for both speciation and quantitation of organisms (12, 21, 30).”
Identification of Aspergillus Species Using Internal Transcribed Spacer Regions 1 and 2
Henry, T., Iwen, P. C., & Hinrichs, S. H. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.4.1510-1515.2000 · Cited by 372 · cited 1×
“Since there are approximately 100 copies of the 18S rRNA gene in the Aspergillus genome (17), selection of this target was expected to substantially increase the sensitivity of the method.”
A rapid, efficient method for isolating DNA from yeast
Holm, C., Meeks-Wagner, D. W., Fangman, W. L., & Botstein, D. (1986) · Gene · doi:10.1016/0378-1119(86)90293-3 · Cited by 345
Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J., & Douglas, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1480 · Cited by 320
Self-citationQuantitative Real-Time PCR for Porphyromonas gingivalis and Total Bacteria
Lyons, S. R., Griffen, A. L., & Leys, E. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.6.2362-2365.2000 · Cited by 289
Loeffler, J., Henke, N., Hebart, H., Schmidt, D., Hagmeyer, L., Schumacher, U., & Einsele, H. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.586-590.2000 · Cited by 289 · cited 2×
“A recent paper (25) detailed an assay based on the quantitative PCR Light Cycler System (Roche Diagnostics, Indianapolis, Ind.”
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241
Self-citationGlucan Synthase Complex of Aspergillus fumigatus
Beauvais, A., Bruneau, J. M., Mol, P. C., Buitrago, M. J., Legrand, R., & Latgé, J. P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.7.2273-2279.2001 · Cited by 209 · cited 1×
“U79728), presumed to be single copy in the genome (8), was also evaluated as a potential target sequence for qPCR analysis.”
Anaissie, E. J., Bodey, G. P., & Rinaldi, M. G. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963467 · Cited by 205
Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR
Bretagne, S., Costa, J. M., Marmorat-Khuong, A., Poron, F., Cordonnier, C., Vidaud, M., & Fleury-Feith, J. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.5.1164-1168.1995 · Cited by 192
Organism-Dependent Fungicidal Activities of Azoles
Manavathu, E. K., Cutright, J. L., & Chandrasekar, P. H. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3018 · Cited by 190 · cited 1×
“fumigatus show that the number of CFU does not increase over a period of at least 24 h (27), despite obvious increases in hyphal mass.”
Abruzzo, G. K., Gill, C. J., Flattery, A. M., Kong, L., Leighton, C., Smith, J. G., Pikounis, V. B., Bartizal, K., & Rosen, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2310-2318.2000 · Cited by 171 · cited 1×
“, 36th ICAAC) and disseminated (3) models of aspergillosis.”
Self-citationTang, C. M., Holden, D. W., Aufauvre-Brown, A., & Cohen, J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1313 · Cited by 162 · cited 1×
“PCR has been described in several reports as a method with which to detect and speciate organisms in sputum, blood, or other clinical samples from patients with suspected fungal infections (9, 10, 33).”
Molecular diagnosis and epidemiology of fungal infections.
Reiss, E., Tanaka, K., Brücker, G., Chazalet, V., Coleman, D. C., Debeaupuis, J. P., Hanazawa, R., Latgé, J., Lortholary, J., Makimura, K., et al. (1998) · PubMed · Cited by 127
Petraitis, V., Petraitiene, R., Groll, A. H., Bell, A., Callender, D. P., Sein, T., Schaufele, R. L., McMillian, C. L., Bacher, J., & Walsh, T. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2898 · Cited by 118 · cited 2×
“One study exploring the efficacy of LY303366 found no significant difference in fungal CFU burden in the lungs of infected rabbits in a model of pulmonary aspergillosis, despite significant improvements in several parameters of therapeutic efficacy (29).”
Comparison between PCR and Detection of Antigen in Sera for Diagnosis of Pulmonary Aspergillosis
Kawamura, S., Maesaki, S., Noda, T., Hirakata, Y., Tomono, K., Tashiro, T., & Kohno, S. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.1.218-220.1999 · Cited by 105 · cited 1×
“The rRNA gene locus is frequently chosen as the PCR amplicon for both speciation and quantitation of organisms (12, 21, 30).”
Verweij, P. E., Oakley, K. L., Morrissey, J., Morrissey, G., & Denning, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.873 · Cited by 104 · cited 2×
“Evaluation of other 1,3- -D-glucan synthesis (GS) inhibitors (LY303366 and FK463) has been described in models of aspergillosis that employed survival or CFU quantitation in selected organs as an endpoint (28, 29, 34).”
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis
Matsumoto, S., Wakai, Y., Nakai, T., Hatano, K., Ushitani, T., Ikeda, F., Tawara, S., Goto, T., Matsumoto, F., & Kuwahara, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.619-621.2000 · Cited by 89 · cited 1×
“Evaluation of other 1,3- -D-glucan synthesis (GS) inhibitors (LY303366 and FK463) has been described in models of aspergillosis that employed survival or CFU quantitation in selected organs as an endpoint (28, 29, 34).”
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Krupa, D. A., Pikounis, V. B., Kropp, H., & Bartizal, K. F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.5.1077 · Cited by 78 · cited 1×
“albicans MY1055 reported a similar increase in CFU over the same period (1).”
Self-citationhyp Loci Control Cell Pattern Formation in the Vegetative Mycelium of Aspergillus nidulans
Kaminskyj, S. G. W., & Hamer, J. E. (1998) · Genetics · doi:10.1093/genetics/148.2.669 · Cited by 76
Amicosante, M., Richeldi, L., Trenti, G., Paone, G., Campa, M., Bisetti, A., & Saltini, C. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.629-630.1995 · Cited by 68 · cited 1×
“Unlike some reports in the literature in which inhibitors of PCR have been noted in certain tissues (5), the method of sample preparation developed for this assay generated a template that could be amplified regardless of tissue type.”
Brandt, M. E., Padhye, A. A., Mayer, L. W., & Holloway, B. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2057-2062.1998 · Cited by 57 · cited 1×
“PCR has been described in several reports as a method with which to detect and speciate organisms in sputum, blood, or other clinical samples from patients with suspected fungal infections (9, 10, 33).”
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis
Kurtz, M. B., Bernard, E. M., Edwards, F. F., Marrinan, J. A., Dropinski, J., Douglas, C. M., & Armstrong, D. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1784 · Cited by 49 · cited 1×
“fumigatus hyphae both in vitro (23) and in vivo (22).”
Self-citation
Cited by
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R., et al. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.165-256.2006 · Cited by 1,318
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Maertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Laboratory diagnosis of invasive aspergillosis
Hope, W., Walsh, T., & Denning, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70238-3 · Cited by 495
Requisite Role for the Dectin-1 β-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus
Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I., Brown, G. D., & Steele, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804250 · Cited by 412
Metadata
- Authors
- Bowman, J. C., Abruzzo, G. K., Anderson, J. W., Flattery, A. M., Gill, C. J., Pikounis, V. B., Schmatz, D. M., Liberator, P. A., & Douglas, C. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2001-12
- Volume
- 45
- Issue
- 12
- Pages
- 3474-3481
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1997351409
- Cited by
- 208
- References
- 32
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.